Edap Tms (NASDAQ:EDAP) Stock Rating Lowered by StockNews.com

Edap Tms (NASDAQ:EDAP) was downgraded by StockNews.com from a “hold” rating to a “sell” rating in a report issued on Tuesday.

Separately, HC Wainwright restated a “buy” rating and set a $19.00 price target on shares of Edap Tms in a research report on Thursday, August 29th.

Edap Tms Stock Down 8.2 %

EDAP stock opened at $3.21 on Tuesday. The company has a debt-to-equity ratio of 0.03, a quick ratio of 2.00 and a current ratio of 2.45. The company has a market capitalization of $118.92 million, a price-to-earnings ratio of -5.94 and a beta of 0.45. Edap Tms has a fifty-two week low of $2.71 and a fifty-two week high of $8.50. The stock has a fifty day moving average of $4.53 and a 200-day moving average of $5.94.

Institutional Inflows and Outflows

Hedge funds have recently modified their holdings of the business. Roubaix Capital LLC bought a new stake in shares of Edap Tms in the first quarter worth $169,000. Miracle Mile Advisors LLC bought a new stake in shares of Edap Tms in the first quarter worth $136,000. Virtu Financial LLC bought a new stake in shares of Edap Tms in the first quarter worth $82,000. Finally, Commonwealth Equity Services LLC grew its holdings in shares of Edap Tms by 5.9% in the second quarter. Commonwealth Equity Services LLC now owns 71,260 shares of the medical equipment provider’s stock worth $388,000 after acquiring an additional 4,000 shares during the period. Hedge funds and other institutional investors own 62.74% of the company’s stock.

Edap Tms Company Profile

EDAP TMS SA, together with its subsidiaries, develops, produces, markets, distributes, and maintains a portfolio of minimally invasive medical devices for the treatment of urological diseases in Asia, France, the United States, and internationally. The company operates through High Intensity Focused Ultrasound (HIFU), Extracorporeal ShockWave Lithotripsy (ESWL), and Distribution Services (DIST) segments.